14 results on '"Muldoon Jacobs, K."'
Search Results
2. Safety evaluation of certain food additives
- Author
-
Barlow, S., Bend, J., Benford, D., Cantrill, R., Dessipri, E., Dinovi, M., Folmer, D., Mattia, A., Mueller, U., Orisakwe, O. E., Smith, J., Veerabhadra Rao, M., Yoon, H. J., Andersen, J. H., Barrows, J. N., Boon, P., Bruno, A., Choi, M., Dejager, L., Fallico, B., Fan, Y., Fattori, V., Gürtler, R., Hallstrom, H., Jia, X., Kim, S., Lambré, C., Laurvick, K., Leblanc, J. C., Lipp, M., Muldoon Jacobs, K., Mulholland, C., Odrowaz, J., Petersen, K., Rosenfeld, L., Rotstein, J., Sheffer, M., Srinivasan, J. R., Tada, A., Tritscher, A., Umemura, T., Yamamoto, R., Yang, X., and Zhang, L.
- Published
- 2019
3. Evaluation of certain food additives: eighty-fourth report of the Joint FAO/WHO Expert Committee on Food Additives
- Author
-
Barlow, S., Bend, J., Benford, D., Cantrill, R., Dessipri, E., Dinovi, M., Folmer, D., Mattia, A., Mueller, U., Orisakwe, O. E., Smith, J., Veerabhadra Rao, M., Yoon, H. J., Andersen, J. H., Barrows, J. N., Boon, P., Bruno, A., Choi, M., Dejager, L., Fallico, B., Fan, Y., Fattori, V., Gürtler, R., Hallstrom, H., Jia, X., Kim, S., Lambré, C., Laurvick, K., Leblanc, J. C., Lipp, M., Muldoon Jacobs, K., Mulholland, C., Odrowaz, J., Petersen, K., Rosenfeld, L., Rotstein, J., Sheffer, M., Srinivasan, J. R., Tada, A., Tritscher, A., Umemura, T., Yamamoto, R., Yang, X., and Zhang, L.
- Subjects
BRILLIANT BLUE FCF ,15'-DIOXYGENASE ACTIVITYT ,FD-AND-C ,CAROTENE 15 ,CAROTENE 15,15'-DIOXYGENASE ACTIVITYT - Published
- 2017
4. Compendium of food additive specifications, Joint FAO/WHO Expert Committee on Food Additives, 84th Meeting 2017
- Author
-
Barlow, S., Bend, J., Benford, D., Cantrill, R., Dessipri, E., Dinovi, M., Folmer, D., Mattia, A., Mueller, U., Orisakwe, O. E., Smith, J., Veerabhadra Rao, M., Yoon, H. J., Andersen, J. H., Barrows, J. N., Boon, P., Bruno, A., Choi, M., Dejager, L., Fallico, B., Fan, Y., Fattori, V., Gürtler, R., Hallstrom, H., Jia, X., Kim, S., Lambré, C., Laurvick, K., Leblanc, J. C., Lipp, M., Muldoon Jacobs, K., Mulholland, C., Odrowaz, J., Petersen, K., Rosenfeld, L., Rotstein, J., Sheffer, M., Srinivasan, J. R., Tada, A., Tritscher, A., Umemura, T., Yamamoto, R., Yang, X., and Zhang, L.
- Subjects
food additives ,safety ,impact assessment - Published
- 2017
5. Potential value of animal microphysiological systems.
- Author
-
Brown PC, Hooberman BH, Skinner BL, Wrzesinski C, Petibone DM, Ford KA, Muldoon-Jacobs K, Sung KE, Valerio LG Jr, Sadrieh NN, Howard PC, Goering PL, Skoog SA, Fitzpatrick SC, Chen T, MacGill TC, and Mendrick DL
- Abstract
Microphysiological systems (MPS) are designed to recapitulate aspects of tissue/organ physiology in vivo, thereby providing potential value in safety and efficacy assessments of FDA-regulated products and regulatory decision-making. While there have been significant advances in the development, use, and proposals of qualification criteria for human organ MPS, there remains a gap in the development using animal tissues. Animal MPS may be of value in many areas including the study of zoonotic diseases, assessment of the safety and efficacy of animal therapeutics, and possibly reduction of the use of animals in regulatory submissions for animal therapeutics. In addition, the development of MPS from various animal species enables comparison to animal in vivo data. This comparison, while not always critical for all contexts of use, could help gain confidence in the use and application of human MPS data for regulatory decision-making and for the potential identification of species-specific effects. The use of animal MPS is consistent with the replacement, reduction, and refinement (3Rs) principles of animal use by identifying toxic compounds before conducting in vivo studies and identifying the appropriate species for testing.
- Published
- 2024
- Full Text
- View/download PDF
6. Review of the oral toxicity of cannabidiol (CBD).
- Author
-
Gingrich J, Choudhuri S, Cournoyer P, Downey J, and Muldoon Jacobs K
- Subjects
- Animals, Humans, Male, Cytochrome P-450 Enzyme System metabolism, Carrier Proteins, Drug Interactions, Testosterone, Cannabidiol toxicity, Cannabidiol metabolism
- Abstract
Information in the published literature indicates that consumption of CBD can result in developmental and reproductive toxicity and hepatotoxicity outcomes in animal models. The trend of CBD-induced male reproductive toxicity has been observed in phylogenetically disparate organisms, from invertebrates to non-human primates. CBD has also been shown to inhibit various cytochrome P450 enzymes and certain efflux transporters, resulting in the potential for drug-drug interactions and cellular accumulation of xenobiotics that are normally transported out of the cell. The mechanisms of CBD-mediated toxicity are not fully understood, but they may involve disruption of critical metabolic pathways and liver enzyme functions, receptor-specific binding activity, disruption of testosterone steroidogenesis, inhibition of reuptake and degradation of endocannabinoids, and the triggering of oxidative stress. The toxicological profile of CBD raises safety concerns, especially for long term consumption by the general population., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
7. Challenges and Opportunities for Improving the Safety Assessment of Botanical Dietary Supplements: A United States Pharmacopeia Perspective.
- Author
-
Oketch-Rabah HA, Roe AL, Muldoon-Jacobs K, and Giancaspro GI
- Subjects
- Animals, Dietary Supplements adverse effects, Humans, Phytotherapy adverse effects, Plant Preparations adverse effects, Risk Assessment, United States, Consumer Product Safety standards, Dietary Supplements standards, Patient Safety standards, Pharmacopoeias as Topic standards, Phytotherapy standards, Plant Preparations standards, Quality Control, Quality Improvement standards
- Abstract
The United States Pharmacopeia (USP) is an independent, nonprofit, science-based organization whose mission is to improve global health through public quality standards for dietary supplements, medicines, and food ingredients.
1 Before developing standards for dietary supplement ingredients, the USP performs an "Admission Evaluation" (Figure 1), which includes an assessment to ascertain that an ingredient does not present a serious health risk.2 This article discusses the challenges encountered during the evaluation of botanicals and proposes possible solutions., (© 2018 American Society for Clinical Pharmacology and Therapeutics.)- Published
- 2018
- Full Text
- View/download PDF
8. Infant toxicology: state of the science and considerations in evaluation of safety.
- Author
-
Neal-Kluever A, Aungst J, Gu Y, Hatwell K, Muldoon-Jacobs K, Liem A, Ogungbesan A, and Shackelford M
- Subjects
- Diet, Endocrine System drug effects, Endocrine System growth & development, Endpoint Determination, Humans, Immune System drug effects, Immune System growth & development, Infant, Nervous System drug effects, Nervous System growth & development, Postnatal Care, Reproducibility of Results, Reproduction drug effects, Risk Assessment, Toxicokinetics, Child Development, Food Packaging, Infant Food analysis, Toxicity Tests methods
- Abstract
Differences in the physiology and biological susceptibilities of adults and infants have led to growing interest in safety evaluation methods for exposures from infant formula packaging. In addition to potential physiological differences, infants aged 0-6 months may consume a sole source of food, infant formula or breast milk, and consume higher amounts of food relative to body weight compared to adults. While the duration of the exposure is short compared to the expected lifespan of the individual, it occurs during a period of important developmental processes. The purpose of this document is to (1) review key biological and exposure elements that may impact the evaluation of safety for food contact products intended for use by infants, (2) summarize the current reproductive and developmental toxicity testing protocols available, and (3) identify potential data gaps concerning this period of development., (Published by Elsevier Ltd.)
- Published
- 2014
- Full Text
- View/download PDF
9. Can the L5178Y Tk+/- mouse lymphoma assay detect epigenetic silencing?
- Author
-
Cheng TF, Patton GW, and Muldoon-Jacobs K
- Subjects
- Aminopterin metabolism, Aminopterin pharmacology, Animals, Antimetabolites, Antineoplastic pharmacology, Cell Line, Tumor, Cell Survival drug effects, Clone Cells, DNA Methylation drug effects, Drug Resistance, Neoplasm drug effects, Evaluation Studies as Topic, Hypoxanthine metabolism, Leukemia L5178 drug therapy, Leukemia L5178 enzymology, Mice, Mutation drug effects, Neoplasm Proteins genetics, Thymidine metabolism, Thymidine Kinase genetics, Trifluridine metabolism, Trifluridine pharmacology, Antimetabolites, Antineoplastic metabolism, Epigenetic Repression drug effects, Leukemia L5178 metabolism, Mutagenicity Tests, Mutagens toxicity, Neoplasm Proteins metabolism, Thymidine Kinase metabolism
- Abstract
The mouse lymphoma L5178Y Tk(+/-) assay is broadly used in toxicology to assess genotoxicity because of its known sensitivity to genotoxicants that act through a variety of mechanisms, which may include epigenetic DNA methylation. This brief article highlights the studies that have contributed to this conjecture and suggests an addition to the experimental design that could identify if the test substance is a potential epimutagen acting via hypermethylation., (Copyright © 2013. Published by Elsevier Ltd.)
- Published
- 2013
- Full Text
- View/download PDF
10. Epigenetic targets of some toxicologically relevant metals: a review of the literature.
- Author
-
Cheng TF, Choudhuri S, and Muldoon-Jacobs K
- Subjects
- Animals, DNA Methylation, Histones chemistry, Histones metabolism, Humans, Protein Processing, Post-Translational, RNA, Untranslated, Environmental Pollutants toxicity, Epigenesis, Genetic, Gene Expression drug effects, Metals, Heavy toxicity, Organometallic Compounds toxicity
- Abstract
The term epigenetics was coined in the context of developmental studies, but the meaning of the term has evolved over time. Epigenetic modulators of gene expression are now known to include DNA methylation, chromatin modifications and noncoding RNAs. The observation that epigenetic changes can be transmitted transgenerationally makes the science of epigenetics very relevant to the field of environmental and molecular toxicology. Heavy metals constitute an important class of environmental contaminants that have been known to influence gene expression directly by binding various metal response elements in the target gene promoters. Recent research suggests that metals can also influence gene expression through epigenetic mechanisms; this adds a new twist to the complexity of metal-mediated gene expression. Here, we review recent studies that investigate the epigenetic, gene expression, and biological effects of various inorganic and organic forms of heavy metals, such as cadmium, arsenic, nickel, chromium, methylmercury, lead, copper and organotin compounds., (Copyright © 2012 John Wiley & Sons, Ltd.)
- Published
- 2012
- Full Text
- View/download PDF
11. Regulatory use of computational toxicology tools and databases at the United States Food and Drug Administration's Office of Food Additive Safety.
- Author
-
Arvidson KB, Chanderbhan R, Muldoon-Jacobs K, Mayer J, and Ogungbesan A
- Subjects
- Animals, Computational Biology methods, Humans, Safety, Toxicology methods, United States, Computational Biology legislation & jurisprudence, Databases, Factual legislation & jurisprudence, Food Additives adverse effects, Toxicology legislation & jurisprudence, United States Food and Drug Administration legislation & jurisprudence
- Abstract
Over 10 years ago, the Office of Food Additive Safety (OFAS) in the FDA's Center for Food Safety and Applied Nutrition implemented the formal use of structure-activity relationship analysis and quantitative structure-activity relationship (QSAR) analysis in the premarket review of food-contact substances. More recently, OFAS has implemented the use of multiple QSAR software packages and has begun investigating the use of metabolism data and metabolism predictive models in our QSAR evaluations of food-contact substances. In this article, we provide an overview of the programs used in OFAS as well as a perspective on how to apply multiple QSAR tools in the review process of a new food-contact substance.
- Published
- 2010
- Full Text
- View/download PDF
12. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress.
- Author
-
Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, and Gius D
- Subjects
- Animals, Breast Neoplasms genetics, Breast Neoplasms metabolism, Female, Fibroblasts metabolism, Humans, Immunohistochemistry, Mice, Mice, Knockout, Oxidative Stress physiology, Sirtuin 3 metabolism, Superoxides metabolism, Aging physiology, Cell Transformation, Neoplastic genetics, Genes, Tumor Suppressor, Mitochondria metabolism, Sirtuin 3 genetics, Stress, Physiological physiology
- Abstract
The sirtuin gene family (SIRT) is hypothesized to regulate the aging process and play a role in cellular repair. This work demonstrates that SIRT3(-/-) mouse embryonic fibroblasts (MEFs) exhibit abnormal mitochondrial physiology as well as increases in stress-induced superoxide levels and genomic instability. Expression of a single oncogene (Myc or Ras) in SIRT3(-/-) MEFs results in in vitro transformation and altered intracellular metabolism. Superoxide dismutase prevents transformation by a single oncogene in SIRT3(-/-) MEFs and reverses the tumor-permissive phenotype as well as stress-induced genomic instability. In addition, SIRT3(-/-) mice develop ER/PR-positive mammary tumors. Finally, human breast and other human cancer specimens exhibit reduced SIRT3 levels. These results identify SIRT3 as a genomically expressed, mitochondria-localized tumor suppressor., (Copyright (c) 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
13. DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells.
- Author
-
Mishra MV, Bisht KS, Sun L, Muldoon-Jacobs K, Awwad R, Kaushal A, Nguyen P, Huang L, Pennington JD, Markovina S, Bradbury CM, and Gius D
- Subjects
- Animals, Antineoplastic Agents pharmacology, Azacitidine pharmacology, Cell Line, Tumor, DNA (Cytosine-5-)-Methyltransferase 1, DNA (Cytosine-5-)-Methyltransferases deficiency, Drug Screening Assays, Antitumor, Humans, Hydrogen Peroxide pharmacology, Oxidative Stress drug effects, Phenotype, Proto-Oncogene Proteins c-fos metabolism, Rats, DNA Methyltransferase 3B, DNA (Cytosine-5-)-Methyltransferases metabolism, Drug Resistance, Neoplasm drug effects, Neoplasms enzymology, Neoplasms pathology
- Abstract
We have previously shown that hydrogen peroxide-resistant permanent (OC-14) cells are resistant to the cytotoxicity of several exogenous oxidative and anticancer agents including H(2)O(2), etoposide, and cisplatin; and we refer to this process as an oxidative multimodality-resistant phenotype (MMRP). Furthermore, OC-14 cells contain increased activator protein 1 activity, and inhibition of activator protein 1 reversed the MMRP. In this study, we show that permanent Rat-1 cell lines genetically altered to overexpress c-Fos also displayed a similar MMRP to H(2)O(2), etoposide, and cisplatin as OC-14 cells. Gene expression analysis of the OC-14 cells and c-Fos-overexpressing cells showed increased DNMT1 expression. Where OC-14 and c-Fos-overexpressing cells were exposed to 5-aza-2'-deoxycytidine, which inhibits DNMT activity, a significant but incomplete reversal of the MMRP was observed. Thus, it seems logical to suggest that DNMT1 might be at least one target in the MMRP. Rat-1 cells genetically altered to overexpress DNMT1 were also shown to be resistant to the cytotoxicity of H(2)O(2), etoposide, and cisplatin. Finally, somatic HCT116 knockout cells that do not express either DNMT1 (DNMT1(-/-)) or DNMT3B (DNMT3B(-/-)) were shown to be more sensitive to the cytotoxicity of H(2)O(2), etoposide, and cisplatin compared with control HCT116 cells. This work is the first example of a role for the epigenome in tumor cell resistance to the cytotoxicity of exogenous oxidative (H(2)O(2)) or systemic (etoposide and cisplatin) agents and highlights a potential role for DNMT1 as a potential molecular target in cancer therapy.
- Published
- 2008
- Full Text
- View/download PDF
14. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA.
- Author
-
Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg AP, and Cui H
- Subjects
- Animals, Cell Differentiation, Cell Line, Tumor, Cyclin-Dependent Kinase Inhibitor p15 biosynthesis, DNA Methylation, Embryonic Stem Cells cytology, Embryonic Stem Cells metabolism, Gene Expression Regulation, Neoplastic genetics, Heterochromatin genetics, Heterochromatin metabolism, Leukemia genetics, Mice, Models, Genetic, Promoter Regions, Genetic genetics, RNA, Antisense metabolism, Ribonuclease III genetics, Ribonuclease III metabolism, Cyclin-Dependent Kinase Inhibitor p15 genetics, Epigenesis, Genetic, Genes, Tumor Suppressor, RNA, Antisense genetics
- Abstract
Tumour suppressor genes (TSGs) inhibiting normal cellular growth are frequently silenced epigenetically in cancer. DNA methylation is commonly associated with TSG silencing, yet mutations in the DNA methylation initiation and recognition machinery in carcinogenesis are unknown. An intriguing possible mechanism for gene regulation involves widespread non-coding RNAs such as microRNA, Piwi-interacting RNA and antisense RNAs. Widespread sense-antisense transcripts have been systematically identified in mammalian cells, and global transcriptome analysis shows that up to 70% of transcripts have antisense partners and that perturbation of antisense RNA can alter the expression of the sense gene. For example, it has been shown that an antisense transcript not naturally occurring but induced by genetic mutation leads to gene silencing and DNA methylation, causing thalassaemia in a patient. Here we show that many TSGs have nearby antisense RNAs, and we focus on the role of one RNA in silencing p15, a cyclin-dependent kinase inhibitor implicated in leukaemia. We found an inverse relation between p15 antisense (p15AS) and p15 sense expression in leukaemia. A p15AS expression construct induced p15 silencing in cis and in trans through heterochromatin formation but not DNA methylation; the silencing persisted after p15AS was turned off, although methylation and heterochromatin inhibitors reversed this process. The p15AS-induced silencing was Dicer-independent. Expression of exogenous p15AS in mouse embryonic stem cells caused p15 silencing and increased growth, through heterochromatin formation, as well as DNA methylation after differentiation of the embryonic stem cells. Thus, natural antisense RNA may be a trigger for heterochromatin formation and DNA methylation in TSG silencing in tumorigenesis.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.